Skip to main content
. 2007 May 23;14(8):1045–1049. doi: 10.1128/CVI.00127-07

TABLE 1.

Numbers and percentages of positive cases obtained by six ELISAs for Chagas' disease diagnosis using the TESA blot as a reference test

Status of patients No. of cases No. (%) of positive cases by:
TESA blot (IMT)a ELISA-IMTa,b Chagas III (BIOSChile)b ELISAcruzi (bioMérieux Brasil SA)b Chagatek (bioMérieux Brasil SA)b Chagatest Rec v3.0 (Wiener)c Pathozyme Chagas (Omega)c
Study 1 187
    Chagas' disease patients 53 53 (100) 53 (100) 53 (100) 53 (100) 53 (100) 53 (100) 53 (100)
    Subjects without Chagas' disease 134
        Healthy 45 0 0 0 1 (2.22) 0 0 0
        VLd 13 0 12 (92.31) 12 (92.31) 11 (84.60) 11 (84.60) 0 0
        CLe 8 0 6 (75.00) 1 (12.50) 7 (87.50) 6 (75.00) 0 0
        T. rangeli 23 0 2 (8.69) 0 0 0 0 0
        Other infections 45 0 0 0 4 (8.88) 0 0 0
Study 2 (Panamanians) 120 16 (13.33) 18 (15.00) 16 (13.33) 18 (15.00) 18 (15.00) 13 (10.83) 12 (10.00)
    TESA blot positive 16 16 (100) 16 (100) 15 (93.75) 15 (93.75) 16 (100) 13 (81.25) 12 (75.00)
    TESA blot negative 104 0 2 (1.92) 1 (0.96) 3 (2.88) 2 (1.92) 0 0
a

Test prepared at the IMT.

b

ELISA prepared with T. cruzi epimastigote antigens.

c

ELISA prepared with T. cruzi recombinant proteins.

d

VL, visceral leishmaniasis.

e

CL, cutaneous leishmaniasis.